Asbury Park, New Jersey Inpatient Drug Rehab Facilities

Jeffrey A. Berman, MD, FASAM is a Diplomate and Fellow of the American Society of Addiction Medicine. He is the Executive Medical Director of Discovery Institute for Addictive Disorders in Marlboro, NJ and Clinical Assistant Professor of Psychiatry at the Robert Wood Johnson Medical School. He was recruited from Bergen Regional Medical Center, NJ’s largest acute psychiatric hospital, where he served as Director of Chemical Dependency Services to join Discovery Institute in Marlboro. Dr. Berman is a diplomate of the American Board of Psychiatry and Neurology (ABPN) in Adult and Addiction Psychiatry as well as Psychosomatic Medicine. He has been certified by the American Society of Addiction Medicine since 1988 and is Board Certified in Addiction Medicine (ABAM). Dr. Berman’s area of special interest in research and teaching is Pain Management and Co-occurring Opioid Dependence. He is also a strong advocate for Medication Assisted Treatment (MAT) for the chronic persistent mentally ill. Dr. Berman participated in NIDA’s clinical trials of Buprenorphine/Naloxone for treatment of heroin addiction in 2001. Since then he has developed innovative treatment programs for individuals with Co-occurring disorders as well as Substance Use Disorders. Dr. Berman served as Chief of Psychiatry at Fort Leavenworth, KS including the Department of Defense’s US Disciplinary Barracks located at Fort Leavenworth. He recently retired from the US Army Reserve after 22 years of service which included service in Operations Desert Storm and Iraqi Freedom. He is currently the Psychiatric Consultant to the Department of Immigration Health (DIHS), a division of Homeland security. Prior to coming to New Jersey, he served as Medical Director of Gieisinger Health Care’s Marworth chemical dependency center and consultant to pain management centers in New Jersey and Pennsylvania for issues of addiction, pain and co-occurring mood disorders. He has taken an active role in the medical treatment of HIV patients in all of these clinical settings.

David Dorschu, MS, has over fifteen years of experience in the substance abuse field, serving in various leadership positions, including Clinical Director, Risk Management Director, QA Director, Outpatient Program Director, and currently as CEO of our substance abuse center at Lighthouse located in Mays Landing, NJ. David has utilized these various leadership roles to form a treatment philosophy based on the latest, empirically supported research.

Charles E. Meusburger, MD is a graduate of the University of Rome Medical School and completed his residency at Thomas Jefferson University Hospital in Philadelphia, Pa. He is a Board Certified Diplomat of Neurology and Psychiatry and has been a practicing psychiatrist for more than 25 years. A former Department Chairman of Psychiatry, Residency Director and Medical Director for Behavioral Health Services in a large health system, Dr. Meusburger is an independent practitioner specializing in adult and adolescent psychiatry. He takes pride in providing his patients full 60-minute sessions in order to best understand their unique behavioral health needs and individual goals. He is distinguished among his patients for delivering superior clinical skills in a caring, compassionate and deeply sensitive manner. Though Dr. Meusburger has a thriving private practice, he also serves as the psychiatrist for a community mental health program that cares for homeless individuals with intellectual and behavioral disabilities. Dr. Meusburger is a speaker on many topics and a published author of numerous articles on behavioral health conditions and management.